Mustang Bio Stock (NASDAQ: MBIO) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 24.000 / 205.300K |
Day Range | - - - |
52 Wk Range | 0.330 - 8.170 |
Market Cap | $3.534M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 23 |
Short Interest | 2.37% |
Days to Cover | 1.01 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Mustang Bio (NASDAQ: MBIO) through any online brokerage.
Other companies in Mustang Bio’s space includes: Tharimmune (NASDAQ:THAR), Dermata Therapeutics (NASDAQ:DRMA), Quoin Pharmaceuticals (NASDAQ:QNRX), Cyclacel Pharmaceuticals (NASDAQ:CYCC) and Geovax Labs (NASDAQ:GOVX).
The latest price target for Mustang Bio (NASDAQ: MBIO) was reported by Cantor Fitzgerald on Thursday, August 24, 2023. The analyst firm set a price target for 18.00 expecting MBIO to rise to within 12 months (a possible 5192.56% upside). 7 analyst firms have reported ratings in the last year.
The stock price for Mustang Bio (NASDAQ: MBIO) is $0.3401 last updated April 23, 2024 at 5:46 PM EDT.
There are no upcoming dividends for Mustang Bio.
Mustang Bio’s Q1 earnings are confirmed for Friday, May 10, 2024.
There is no upcoming split for Mustang Bio.
Mustang Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.